We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Protective Coating Helps Leishmania to Resist Macrophage Digestion

By Biotechdaily staff writers
Posted on 12 Aug 2003
Researchers studying the molecular mechanism that allows the leishmania parasite to survive inside macrophages, blood cells that usually destroy pathogenic microorganisms, have found that while the major surface lipophosphoglycan (LPG) is critical to the survival of the parasite, other molecules must collaborate with it.

Epidemiologists estimate that about 12 million people worldwide are infected with leishmania parasites. The parasite is spread by the bite of sand flies and causes various types of cutaneous and visceral diseases.

Investigators at Washington University School of Medicine (St. Louis, MO, USA) focused their studies on the role of LPG, which is abundantly expressed on the surface of parasite. Their paper published July 17, 2003, in the online edition of Proceedings of the National Academy of Sciences described the use of a strain of the parasite that was genetically engineered to lack the gene for LPG production.

Parasites without LPG were found to be ten times more vulnerable to attack by complement, and although parasites that lacked LPG invaded macrophages, they were quickly destroyed by oxidative mechanisms once inside the cells. On the other hand, parasites without LPG retained the ability to resist macrophage hydrolytic and proteolytic defenses.

"This study helps us better understand how these parasites are transmitted and how they establish infections,” said senior author Dr. Stephen M. Beverley, professor of molecular microbiology at Washington University. "It also could help efforts leading to the development of a vaccine to prevent this devastating disease.”




Related Links:
Washington University

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Hematology Consumables
Bioblood Devices
New
Repetitive Pipette
VWR® Stepper Pro

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
12 Aug 2003  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
12 Aug 2003  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
12 Aug 2003  |   BioResearch